🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
According to literature reports, about 16.3%-19% of newly diagnosed NSCLC p...
Status
Unknown
Location
Chongqing University Cancer Hospital
Start Date
2021-03-01
Trial ID
NCT04905550
BDTX-1535-101 is an open-label, Phase 1 dose escalation and Phase 2 multipl...
Status
Active Not Recruiting
Location
University of Alabama
Start Date
2022-03-31
Trial ID
NCT05256290
Treatments Being Tested
The purpose of this randomized study is to determine the safety and efficac...
Status
Recruiting
Location
Valkyrie Clinical Trials
Start Date
2021-09-03
Trial ID
NCT04486833
Treatments Being Tested
This is a nonrandomized, open phase I dose escalation and extension clinica...
Status
Unknown
Location
Zhangli
Start Date
2022-09-21
Trial ID
NCT05489731
Treatments Being Tested
This is a phase II clinical study evaluating the safety, tolerability, phar...
Status
Recruiting
Location
SunYat-sen University Cancer Center
Start Date
2026-07-10
Trial ID
NCT07669779
Treatments Being Tested
To explore the intracranial/extracranial ORR, PFS, QoL, safety, dynamic cha...
Status
Unknown
Location
The Second Affiliated Hospital of Shandong First Medical University
Start Date
2022-12-01
Trial ID
NCT05754736
Treatments Being Tested
A Prospective Study of Zorifertinib Combined with Intra-Ommaya Reservoir Ce...
Status
Not Yet Recruiting
Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2026-05-30
Trial ID
NCT07551414
Treatments Being Tested
AMAZE-lung is a multicenter single-arm phase II trial. The protocol treatme...
Status
Active Not Recruiting
Location
Chu Angers
Start Date
2023-03-27
Trial ID
NCT05601973
Treatments Being Tested
This is a prospective, open-label, multi-center, single-arm clinical trial...
Status
Not Yet Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2026-05-01
Trial ID
NCT07343479
Treatments Being Tested
To evaluate the safety and tolerability of IBI3005 combination therapy in p...
Status
Not Yet Recruiting
Location
SunYat-sen University Cancer Center
Start Date
2026-06-01
Trial ID
NCT07612137
Treatments Being Tested